QQ客服 官方微博 反馈留言

	Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects
	Gong, Shiqiang; Han, Xiaowan; Li, Xuehong; Yang, Jun; He, Xiaobo; Si, Shuyi
	2016
卷号	21期号:7页码:738-748
关键词	osteoprotegerin (OPG) receptor activator of NF-B ligand (RANKL) high-throughput screening (HTS) osteoporosis
ISSN号	1087-0571
DOI	10.1177/1087057116654657
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6383802
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Gong, Shiqiang,Han, Xiaowan,Li, Xuehong,et al. Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects[J],2016,21(7):738-748.
APA	Gong, Shiqiang,Han, Xiaowan,Li, Xuehong,Yang, Jun,He, Xiaobo,&Si, Shuyi.(2016).Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects.,21(7),738-748.
MLA	Gong, Shiqiang,et al."Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects".21.7(2016):738-748.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。